IPO of Achilles Therapeutics plc.

Achilles Therapeutics plc. has placed 9 750 000 American Depositary shares (ADSs) in an IPO priced $18 per share, which is a medium of the previously announced range ($17-19). Besides, Achilles has granted the underwriters a 30-day option to purchase up to 1 462 500 shares at the public offering price. 

The trading debut will take place on the Nasdaq Global Select Market on March 31, 2021 under the ticker symbol «ACHL».